Construction and Gene Expression Analysis of a Single-Stranded DNA Minivector Based on an Inverted Terminal Repeat of Adeno-Associated Virus

Molecular Biotechnology

Volumn 57, Issue 4, 2015, Pages 382-390

  Ping, Han ^a,b   Liu, Xiaomei ^a   Zhu, Dongqin ^a   Li, Taiming ^b   Zhang, Chun ^a  

^a SUZHOU INSTITUTE OF BIOMEDICAL ENGINEERING AND TECHNOLOGY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Adeno associated virus (AAV); D sequence; Gene transfer; Inverted terminal repeat (ITR); Single stranded DNA minivector

Indexed keywords

DNA; DNA SEQUENCES; GENE THERAPY; GENE TRANSFER; GENES; VIRUSES;

ADENO-ASSOCIATED VIRUS; ANTIBIOTIC RESISTANCE GENES; DOUBLE-STRANDED DNA (DS-DNA); EXPRESSION EFFICIENCY; GENE EXPRESSION ANALYSIS; INVERTED TERMINAL REPEAT (ITR); NONVIRAL GENE TRANSFER; SINGLE-STRANDED DNA;

GENE EXPRESSION;

COMPLEMENTARY DNA; DOUBLE STRANDED DNA; GREEN FLUORESCENT PROTEIN; NUCLEOTIDE; OLIGONUCLEOTIDE; PALINDROMIC DNA; PARVOVIRUS VECTOR; PLASMID DNA; SINGLE STRANDED DNA; ENHANCED GREEN FLUORESCENT PROTEIN;

ADENO ASSOCIATED VIRUS; AGAR GEL ELECTROPHORESIS; ARTICLE; AUTOMATION; CONTROLLED STUDY; DNA DENATURATION; DNA FLANKING REGION; DNA HAIRPIN; DNA REPLICATION; DNA REPLICATION ORIGIN; DNA STRUCTURE; DNA SYNTHESIS; EMBRYO; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE DELETION; GENE SEQUENCE; GENETIC TRANSFECTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; INVERTED TERMINAL REPEAT; NONHUMAN; PLASMID; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS GENOME; CHEMISTRY; DEPENDOPARVOVIRUS; GENE EXPRESSION; GENETICS; LONG TERMINAL REPEAT; METABOLISM; MOLECULAR CLONING; PROCEDURES;

ADENO-ASSOCIATED VIRUS; BACTERIA (MICROORGANISMS);

CLONING, MOLECULAR; DEPENDOVIRUS; DNA, SINGLE-STRANDED; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; PLASMIDS; TERMINAL REPEAT SEQUENCES; TRANSFECTION;

EID: 84925866144     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-014-9832-3     Document Type: Article

References (26)

1. Lyon, A. R., Sato, M., Hajjar, R. J., Samulski, R. J., & Harding, S. E. (2008). Gene therapy: Targeting the myocardium. Heart,94, 89–99.
2. Somia, N., & Verma, I. M. (2000). Gene therapy: Trials and tribulations. Nature Reviews Genetics,1, 91–99.
3. Couzin, J., & Kaiser, J. (2005). Gene therapy. As Gelsinger case ends, gene therapy suffers another blow. Science,307, 1028.
4. Gao, X., Kim, K. S., & Liu, D. (2007). Nonviral gene delivery: What we know and what is next. The AAPS Journal,9, 92–104.
5. Gill, D. R., Pringle, I. A., & Hyde, S. C. (2009). Progress and prospects: The design and production of plasmid vectors. Gene Therapy,16, 165–171.
6. Schwartz, D. A., Quinn, T. J., Thorne, P. S., Sayeed, S., Yi, A. K., & Krieg, A. M. (1999). CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. Journal of Clinical Investigation,100, 68–73.
7. Jechlinger, W. (2006). Optimization and delivery of plasmid DNA for vaccination. Expert Review of Vaccines,5, 803–825.
8. Levy, M. S., O’Kennedy, R. D., Ayazi-Shamlou, P., & Dunnill, P. (2000). Biochemical engineering approaches to the challenges of producing pure plasmid DNA. Trends in Biotechnology,18, 296–305.
9. Lengsfeld, C. S., & Anchordoquy, T. J. (2002). Shear-induced degradation of plasmid DNA. Journal of Pharmaceutical Sciences,91, 1581–1589.
10. Jechlinger, W., Azimpour, T. C., Lubitz, W., & Mayrhofer, P. (2004). Minicircle DNA immobilized in bacterial ghosts: In vivo production of safe non-viral DNA delivery vehicles. Journal of Molecular Microbiology and Biotechnology,8, 222–231.
11. Chen, Z. Y., He, C. Y., Meuse, L., & Kay, M. A. (2004). Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. Gene Therapy,11, 856–864.
12. Chen, Z. Y., He, C. Y., & Kay, M. A. (2005). Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. Human Gene Therapy,16, 126–131.
13. Darquet, A. M., Cameron, B., Wils, P., Scherman, D., & Crouzet, J. (1997). A new DNA vehicle for nonviral gene delivery: Supercoiled minicircle. Gene Therapy,4, 1341–1349.
14. McCarty, D. M. (2008). Self-complementary AAV vectors; advances and applications. Molecular Therapy,16, 1648–1656.
15. Penaud-Budloo, M., Le Guiner, C., Nowrouzi, A., Toromanoff, A., Chérel, Y., Chenuaud, P., et al. (2008). Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle. Journal of Virology,82, 7875–7885.
16. Yiang, G. T., Chou, R. H., Chang, W. J., Wei, C. W., & Yu, Y. L. (2013). Long-term expression of rAAV2-hIL15 enhances immunoglobulin production and lymphokine-activated killer cell-mediated human glioblastoma cell death. Molecular and Clinical Oncology,1, 321–325.
17. Ferrari, F. K., Samulski, T., Shenk, T., & Samulski, R. J. (1996). Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. Journal of Virology,70, 3227–3234.
18. Fisher, K. J., Gao, G. P., Weitzman, M. D., DeMatteo, R., Burda, J. F., & Wilson, J. M. (1996). Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. Journal of Virology,70, 520–532.
19. Duan, D., Sharma, P., Yang, J., Yue, Y., Dudus, L., Zhang, Y., et al. (1998). Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle. Journal of Virology,72, 8568–8577.
20. Schnepp, B. C., Jensen, R. L., Chen, C. L., Johnson, P. R., & Clark, K. R. (2005). Characterization of adeno-associated virus genomes isolated from human tissues. Journal of Virology,79, 14793–14803.
21. Xiao, X., Li, J., & Samulski, R. J. (1996). Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. Journal of Virology,70, 8098–8108.
22. Lusby, E., Fife, K. H., & Berns, K. I. (1980). Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA. Journal of Virology,34, 402–409.
23. Ni, T. H., Zhou, X. H., McCarty, D. M., Zolotukhin, I., & Muzyczka, N. (1994). In vitro replication of adeno-associated virus DNA. Journal of Virology,68, 1128–1138.
24. Wang, X. S., Ponnazhagan, S., & Srivastava, A. (1995). Rescue and replication signals of the adeno-associated virus 2 genome. Journal of Molecular Biology,250, 573–580.
25. Qing, K., Khuntirat, B., Mah, C., Kube, D. M., Wang, X. S., Ponnazhagan, S., et al. (1998). Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. Journal of Virology,72, 1593–1599.
26. Zhong, L., Qing, K., Si, Y., Chen, L., Tan, M., & Srivastava, A. (2004). Heat-shock treatment-mediated increase in transduction by recombinant adeno-associated virus 2 vectors is independent of the cellular heat-shock protein 90. Journal of Biological Chemistry,279, 12714–12723.